EAGLE PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Issued from Q3 2013 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Eagle Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q3 2013 to Q2 2023.
  • Eagle Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2023 was 17.6M shares, a 0.56% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 17.6M +98.4K +0.56% Jun 30, 2023 10-Q/A 2023-08-09
Q1 2023 17.6M +661K +3.89% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 17.6M +666K +3.94% Dec 31, 2022 10-Q/A 2023-08-09
Q3 2022 17.6M +682K +4.04% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 17.5M +669K +3.96% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 17M +118K +0.7% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 16.9M +164K +0.98% Dec 31, 2021 10-K 2023-03-23
Q3 2021 16.9M +261K +1.57% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 16.9M +258K +1.55% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 16.9M +260K +1.57% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 16.7M +201K +1.22% Dec 31, 2020 10-K 2022-03-08
Q3 2020 16.6M +99.8K +0.6% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 16.6M +99.5K +0.6% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 16.6M +78.1K +0.47% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 16.5M +33.6K +0.2% Dec 31, 2019 10-K 2021-03-05
Q3 2019 16.5M +21.6K +0.13% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 16.5M +64.6K +0.39% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 16.5M +353K +2.19% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 16.5M +415K +2.58% Dec 31, 2018 10-K 2020-03-02
Q3 2018 16.5M +432K +2.69% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 16.5M +392K +2.44% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 16.2M +158K +0.99% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 16.1M +199K +1.25% Dec 31, 2017 10-K 2019-02-28
Q3 2017 16.1M +345K +2.19% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 16.1M +430K +2.75% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 16M +371K +2.38% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 15.9M +254K +1.63% Dec 31, 2016 10-K 2018-02-26
Q3 2016 15.7M +136K +0.88% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 15.6M +46.5K +0.3% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 15.6M +127K +0.82% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 15.6M +1.6M +11.4% Dec 31, 2015 10-K 2017-03-15
Q3 2015 15.6M +1.56M +11.1% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 15.6M +1.57M +11.2% Jun 30, 2015 10-Q 2015-08-11
Q1 2015 15.5M +1.49M +10.6% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 14M Dec 31, 2014 10-K 2016-02-29
Q3 2014 14M +11M +360% Sep 30, 2014 10-K 2016-02-29
Q2 2014 14M Jun 30, 2014 10-Q 2014-08-11
Q1 2014 14M Mar 31, 2014 10-Q 2014-05-15
Q3 2013 3.05M Sep 30, 2013 10-K 2014-12-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.